MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 29 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,333,000 | -30.0% | 2,976,121 | 0.0% | 0.07% | -5.4% |
| Q4 2021 | $4,762,000 | -33.9% | 2,976,121 | 0.0% | 0.07% | -21.3% |
| Q3 2021 | $7,202,000 | -23.7% | 2,976,121 | 0.0% | 0.09% | -3.1% |
| Q2 2021 | $9,434,000 | -5.9% | 2,976,121 | 0.0% | 0.10% | -2.0% |
| Q1 2021 | $10,030,000 | -5.9% | 2,976,121 | 0.0% | 0.10% | +16.5% |
| Q4 2020 | $10,655,000 | +154.5% | 2,976,121 | +86.2% | 0.08% | +165.6% |
| Q3 2020 | $4,187,000 | +996.1% | 1,598,185 | +1178.9% | 0.03% | +966.7% |
| Q2 2020 | $382,000 | – | 124,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
| Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
| DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
| J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
| Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
| HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
| F3Logic, LLC | 255 | $668,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
| CSS LLC/IL | 54,773 | $144,000 | 0.01% |